{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~51 mi. (Daphne, Alabama, +207 more cities)
facility
Southern Cancer Center, PC ( Site 8003)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
Naptumomab Estafenatox (NAP) in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC
city
~51 mi. (Daphne, Alabama, +9 more cities)
facility
NeoTX - 10307
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +1 more type
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~53 mi. (Mobile, Alabama, +247 more cities)
facility
University of South Alabama Mitchell Cancer Institute
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~53 mi. (Mobile, Alabama, +176 more cities)
facility
University of South Alabama, Mitchell Cancer Institute ( Site 3058)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~53 mi. (Mobile, Alabama, +454 more cities)
facility
USA Health Strada Patient Care Center
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.
city
~53 mi. (Mobile, Alabama, +230 more cities)
facility
Research Site
biomarker
ER Positive, +1 more biomarker
drug
camizestrant, +3 more drugs
drug type
hormone therapy, +1 more type
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
city
~53 mi. (Mobile, Alabama, +271 more cities)
facility
Local Institution
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +2 more types